Elon Musk, the CEO of Tesla and SpaceX, has been candid about his struggle with weight loss. The billionaire has openly ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.

Read here for a detailed financial analysis of Medifast stock post-pandemic, GLP-1 impact, and the company's collaboration ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and for weight loss, may be linked with a reduced risk of substance use and neurocognitive disorders, a US study in people ...

Navigating the world of nutrition can feel like trying to find your way through a maze of myths and misconceptions. Before ...

A large new study has shed light on the wider health impacts of taking Ozempic-style drugs. Weight-loss drugs like Ozempic ...

GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes.

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...